CBC Group Acquires UCB's Mature Neuroscience Portfolio in China to Enhance Patient Care CBC Group, Asia's premier healthcare investment firm, has acquired UCB's mature neurology and allergy product portfolio to elevate patient outcomes in China.

CBC Group Acquires UCB's Mature Neuroscience Portfolio in China to Enhance Patient Care #Singapore #UCB #CBC_Group #NeuroGen_Pharma